Skip to Content

T. Rowe Price Health Sciences PRHSX

Analyst rating as of
  • NAV / 1-Day Return 90.39  /  0.38 %
  • Total Assets 16.2 Bil
  • Adj. Expense Ratio
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 34%

Morningstar’s Analysis PRHSX

Will PRHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Offers an edge in the healthcare sector.

Senior Analyst



T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.

Unlock our full analysis with Morningstar Investor